Lukatch Heath
- SEC CIK
- 0001596385
No open-market purchases or sales filed in the past year.
Current role at each company
- PCVX Vaxcyte, Inc.Directoras of Jun 16, 2026
- STSA Satsuma Pharmaceuticals, Inc.Directoras of Jun 8, 2023
- FLXN Flexion Therapeutics IncDirectoras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lukatch Heath as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PCVX Vaxcyte, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 (view filing) | Oct 24-26 | 2 days | Lukatch HeathDirector | SSale | −7.01K | $36.90 | −$258.9K | −69.2%3.13K after | 2 lots |
| Nov 15, 2022 (view filing) | Nov 10 | 5 days | Lukatch HeathDirector | SSale | −4.33K | $46.13 | −$200.0K | −58.1%3.13K after | 2 lots |
| Dec 14, 2022 (view filing) | Dec 12 | 2 days | Lukatch HeathDirector | SSale | −335 | $43.93 | −$14.7K | −9.7%3.13K after | 2 lots |
| Jan 12, 2023 (view filing) | Jan 10 | 2 days | Lukatch HeathDirector | SSale | −315 | $46.12 | −$14.5K | −9.2%3.13K after | 2 lots |
| Jan 4, 2024 (view filing) | Jan 2 | 2 days | Lukatch HeathDirector | SSale | −13.0K | $63.76 | −$828.9K | −69.8%5.63K after | 4 lots10b5-1 |
| Jan 31, 2024 (view filing) | Jan 29 | 2 days | Lukatch HeathDirector | SSale | −4.00K | $67.50 | −$270.0K | −41.6%5.63K after | 10b5-1 |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Lukatch HeathDirector | SSale | −5.00K | $71.50 | −$357.5K | −47.1%5.63K after | 10b5-1 |